|1.||Lichtenegger, W: 1 article (11/2000)|
|2.||Heinze, T: 1 article (11/2000)|
|1.||Breast Neoplasms (Breast Cancer)
09/01/1992 - "In conclusion, the results indicate that a new tumour marker TAG 12 is superior to CA 15-3 and MCA in predicting breast cancer recurrence. "
03/01/1994 - "The aim of this study was to assess the clinical value of five serum tumour markers, TPA, TPS, TAG 12, CA 15-3 and MCA, in the diagnosis of breast cancer. "
09/01/1992 - "The aim of the present study was to evaluate the clinical value of the preoperative serum tumour markers TAG 12, CA 15-3 and MCA in predicting a recurrence of breast cancer patients. "
03/01/1994 - "Thus it seems that TPA, TPS, TAG 12, CA 15-3 and MCA have only limited value in breast cancer diagnosis, but their role in the follow-up and prediction of prognosis of breast cancer patients is a subject for further investigation."
03/01/1994 - "The correlation coefficients in breast cancer patients between TPA and TPS measurements was 0.82, between TPA and TAG 12 measurements it was 0.09, between TPA and CA 15-3 measurements it was 0.08, and 0.11 between TPA and MCA measurements. "
|2.||Breast Diseases (Breast Disease)
03/01/1991 - "The aim of the present study was to evaluate the clinical value of the new tumour marker TAG 12 in sera from patients with breast cancer, patients with benign breast disease and normal controls. "
01/01/1992 - "The aim of the present study was to evaluate the clinical value of the new tumour marker TAG 12 in sera from patients with breast cancer (n = 123), patients with benign breast disease (n = 30) and normal controls (n = 38). "
09/01/1991 - "TAG 12 positivity was not significantly related to the following parameters: menopausal status, tumour size, axillary lymph node involvement, histological type of the tumour, DNA ploidy, S-phase fraction or irregularity of tumor cell nuclei. "
01/01/1991 - "Immunodetection of a tumor associated antigen (TAG-12): comparison of microwave accelerated and conventional method."
11/01/2000 - "We compared the preoperative sensitivity of tumor associated glycoprotein (TAG) 12 of 128 primary breast cancer patients with the established tumor marker CA 15-3 and received a similar, even slightly higher sensitivity. "
11/01/2000 - "Tumor associated glycoprotein (TAG) 12: a new tumor marker in breast cancer."
10/01/1994 - "Utilization of anti-Id as a vaccine against the breast cancer-associated tumor antigen TAG-12 was successfully demonstrated in a xenogeneic animal model."
09/01/1991 - "The expression of a novel tumour marker TAG 12 was immunohistochemically determined in paraffin embedded biopsies of 79 female breast carcinomas, with special emphasis on its potential prognostic value. "
01/01/1990 - "A monoclonal antibody 7A9 was raised against the tumour-associated glycoprotein TAG-12 purified from T47-D breast carcinoma cells. "
08/01/1994 - "The mabs, directed against two different epitopes on the mucin glycoprotein TAG-12, showed reactivity with 96% of all primary mammary carcinomas. "
09/01/1991 - "For biochemical analyses, TAG-12 antigen purified from T47-D breast carcinoma cells by lectin affinity chromatography was treated with different glycosidases and proteases and analyzed by immunoblotting with 7A9. "
|5.||Ovarian Neoplasms (Ovarian Cancer)
|7.||Peptide Hydrolases (Proteases)
|9.||Glycoside Hydrolases (Endoglycosidases)
|10.||DNA (Deoxyribonucleic Acid)